Intellia Therapeutics Reports Financial Results for Second Quarter 2016

Go back to Intellia Therapeutics Reports Financial Results for Second Quarter 2016
(NASDAQ: NTLA) Delayed: 12.65 -0.63 (4.74%)
Previous Close $13.28    52 Week High $30.40 
Open $12.95    52 Week Low $11.86 
Day High $13.04    P/E N/A 
Day Low $12.29    EPS $0.00 
Volume 2,241,919